The complication-overall survival (CompOS) risk tool predicts risk of a severe postoperative complications relative to long-term survival among patients with primary liver cancer.

Comprehensive Complication Index Hepatocellular carcinoma Intrahepatic cholangiocarcinoma Multi-institutional database

Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 08 10 2023
revised: 06 12 2023
accepted: 10 12 2023
medline: 6 3 2024
pubmed: 6 3 2024
entrez: 6 3 2024
Statut: ppublish

Résumé

This study aimed to develop a tool based on preoperative factors to predict the risk of perioperative complications based on the Comprehensive Complication Index (CCI) and long-term survival outcomes after liver resection for primary liver cancer. Patients with hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC) undergoing curative-intent hepatectomy between 1990 and 2020 were identified using a multi-institutional international database. Among 1411 patients who underwent curative-intent hepatic resection (HCC: 997, 70.7%; ICC: 414, 29.3%), median patient age was 66.0 years (IQR, 57.0-73.0), and most patients were male (n = 1001, 70.9%). In the postoperative setting, 699 patients (49.5%) experienced a complication; moreover, 112 patients (7.9%) had major complications. Although most patients had a favorable risk complication-overall survival (CompOS) profile (CCI score > 40 risk of <30% and median survival of >5 years: n = 778, 55.1%), 553 patients (39.2%) had an intermediate-risk profile, and 80 patients (5.7%) had a very unfavorable risk profile (CCI score > 40 risk of ≥30% and/or median survival of ≤1.5 years). The areas under the curve of the test and validation cohorts were 0.73 and 0.76, respectively. The CompOS risk model accurately stratified patients relative to short- and long-term risks, identifying a subset of patients at a high risk of major complications and poor overall survival.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to develop a tool based on preoperative factors to predict the risk of perioperative complications based on the Comprehensive Complication Index (CCI) and long-term survival outcomes after liver resection for primary liver cancer.
METHODS METHODS
Patients with hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC) undergoing curative-intent hepatectomy between 1990 and 2020 were identified using a multi-institutional international database.
RESULTS RESULTS
Among 1411 patients who underwent curative-intent hepatic resection (HCC: 997, 70.7%; ICC: 414, 29.3%), median patient age was 66.0 years (IQR, 57.0-73.0), and most patients were male (n = 1001, 70.9%). In the postoperative setting, 699 patients (49.5%) experienced a complication; moreover, 112 patients (7.9%) had major complications. Although most patients had a favorable risk complication-overall survival (CompOS) profile (CCI score > 40 risk of <30% and median survival of >5 years: n = 778, 55.1%), 553 patients (39.2%) had an intermediate-risk profile, and 80 patients (5.7%) had a very unfavorable risk profile (CCI score > 40 risk of ≥30% and/or median survival of ≤1.5 years). The areas under the curve of the test and validation cohorts were 0.73 and 0.76, respectively.
CONCLUSION CONCLUSIONS
The CompOS risk model accurately stratified patients relative to short- and long-term risks, identifying a subset of patients at a high risk of major complications and poor overall survival.

Identifiants

pubmed: 38445934
pii: S1091-255X(23)03730-7
doi: 10.1016/j.gassur.2023.12.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-140

Informations de copyright

Copyright © 2023 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.

Auteurs

Yutaka Endo (Y)

Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, United States.

Diamantis I Tsilimigras (DI)

Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, United States.

Selamawit Woldesenbet (S)

Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, United States.

Hugo P Marques (HP)

Department of Surgery, Hospital Curry Cabral, Lisbon, Portugal.

François Cauchy (F)

Department of Hepatobiliopancreatic Surgery, Assistance Publique-Hôpitaux de Paris, Beaujon Hospital, Clichy, France.

Matthew Weiss (M)

Department of Surgery, Northwell Health, New Hyde Park, New York, United States.

Todd W Bauer (TW)

Department of Surgery, University of Virginia, Charlottesville, Virginia, United States.

George A Poultsides (GA)

Department of Surgery, Stanford University, Palo Alto, California, United States.

Shishir K Maithel (SK)

Department of Surgery, Emory University, Atlanta, Georgia, United States.

Minoru Kitago (M)

Department of Surgery, Keio University, Tokyo, Japan.

Sorin Alexandrescu (S)

Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.

Guillaume Martel (G)

Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada.

Alfredo Guglielmi (A)

Department of Surgery, University of Verona, Verona, Italy.

Carlo Pulitano (C)

Department of Surgery, Royal Prince Alfred Hospital, The University of Sydney, Sydney, New South Wales, Australia.

Ana Gleisner (A)

Department of Surgery, University of Colorado, Denver, Colorado, Unites States.

Tom Hugh (T)

Department of Surgery, School of Medicine, The University of Sydney, Sydney, New South Wales, Australia.

Luca Aldrighetti (L)

Department of Surgery, Ospedale San Raffaele, Milan, Italy.

Feng Shen (F)

Department of Hepatic Surgery IV, the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

Bas G Koerkamp (BG)

Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.

Itaru Endo (I)

School of Medicine, Yokohama City University, Yokohama, Japan.

Timothy M Pawlik (TM)

Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, United States. Electronic address: Tim.Pawlik@osumc.edu.

Classifications MeSH